Related Experiment Video
Updated: Nov 5, 2025

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists
Published on: November 15, 2013
Steroid Ligands, the Forgotten Triggers of Nuclear Receptor Action; Implications for Acquired Resistance to Endocrine
Rachel Bleach1, Stephen F Madden2, James Hawley3
1Endocrine Oncology Research, Department of Surgery, RCSI University of Medicine and Health Sciences, Dublin, Ireland.
Purpose:
There is strong epidemiologic evidence indicating that estrogens may not be the sole steroid drivers of breast cancer. We hypothesize that abundant adrenal androgenic steroid precursors, acting via the androgen receptor (AR), promote an endocrine-resistant breast cancer phenotype.
Experimental Design:
AR was evaluated in a primary breast cancer tissue microarray (n = 844). Androstenedione (4AD) levels were evaluated in serum samples (n = 42) from hormone receptor-positive, postmenopausal breast cancer. Levels of androgens, progesterone, and estradiol were quantified using LC/MS-MS in serum from age- and grade-matched recurrent and nonrecurrent patients (n = 6) before and after aromatase inhibitor (AI) therapy (>12 months). AR and estrogen receptor (ER) signaling pathway activities were analyzed in two independent AI-treated cohorts.
Results:
AR protein expression was associated with favorable progression-free survival in the total population (Wilcoxon, P < 0.001). Pretherapy serum samples from breast cancer patients showed decreasing levels of 4AD with age only in the nonrecurrent group (P < 0.05). LC/MS-MS analysis of an AI-sensitive and AI-resistant cohort demonstrated the ability to detect altered levels of steroids in serum of patients before and after AI therapy. Transcriptional analysis showed an increased ratio of AR:ER signaling pathway activities in patients failing AI therapy (t test P < 0.05); furthermore, 4AD mediated gene changes associated with acquired AI resistance.
Conclusions:
This study highlights the importance of examining the therapeutic consequences of the steroid microenvironment and demonstrable receptor activation using indicative gene expression signatures.
Insights
Adrenal androgens, acting through the androgen receptor (AR), may drive endocrine-resistant breast cancer. Targeting AR and understanding the steroid microenvironment are crucial for effective breast cancer treatment.
Area of Science:
- Endocrinology
- Oncology
- Molecular Biology
Background:
- Estrogens are not the only steroid drivers of breast cancer.
- Adrenal androgenic steroid precursors may promote endocrine-resistant breast cancer via the androgen receptor (AR).
Purpose of the Study:
- To investigate the role of AR and adrenal androgens in breast cancer endocrine resistance.
- To evaluate AR expression and androgen levels in breast cancer patients.
- To analyze AR and estrogen receptor (ER) signaling in response to aromatase inhibitor (AI) therapy.
Main Methods:
- AR protein expression was assessed in breast cancer tissue microarrays.
- Serum androstenedione (4AD) levels were measured.
- Steroid levels (androgens, progesterone, estradiol) were quantified using LC/MS-MS.
- AR and ER signaling pathway activities were analyzed in AI-treated cohorts.
Main Results:
- AR protein expression correlated with favorable progression-free survival.
- Decreasing 4AD levels with age were observed in nonrecurrent breast cancer patients.
- Altered steroid levels were detected before and after AI therapy.
- An increased AR:ER signaling ratio was found in patients resistant to AI therapy.
- 4AD mediated gene changes associated with acquired AI resistance.
Conclusions:
- The steroid microenvironment and receptor activation are important in breast cancer therapy.
- Examining AR signaling and steroid levels can inform breast cancer treatment strategies.
More Related Videos
09:07Detecting the Ligand-binding Domain Dimerization Activity of Estrogen Receptor Alpha Using the Mammalian Two-Hybrid Assay
Published on: December 19, 2018
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
Related Concept Videos
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Signal Transduction: Overview
Typically, signal transduction involves three...
Internal Receptors
Target Cell Response to Hormones
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Intracellular Hormone Receptors
Types of Receptors: Internal Receptors
Similar to membrane-bound receptors, the binding of a ligand to the intracellular receptor of causes a conformational change in the...